Uncini A, Kuwabara S (2015) Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry 86:1186–1195. https://doi.org/10.1136/jnnp-2014-310097

Article  PubMed  Google Scholar 

Van den Bergh PYK, Van Doorn PA, Hadden RDM et al (2021) European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol 28:3556–3583. https://doi.org/10.1111/ene.14959

Article  PubMed  Google Scholar 

Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2013) Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73:370–380. https://doi.org/10.1002/ana.23794

Article  CAS  PubMed  Google Scholar 

Doppler K, Appeltshauser L, Wilhelmi K et al (2015) Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry 86:720–728. https://doi.org/10.1136/jnnp-2014-309916

Article  PubMed  Google Scholar 

Miura Y, Devaux JJ, Fukami Y et al (2015) Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain 138:1484–1491. https://doi.org/10.1093/brain/awv054

Article  PubMed  PubMed Central  Google Scholar 

Vallat JM, Yuki N, Sekiguchi K et al (2017) Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-neurofascin 155 antibodies. Neuromuscul Disord 27:290–293. https://doi.org/10.1016/j.nmd.2016.10.008

Article  PubMed  Google Scholar 

Koike H, Kadoya M, Kaida KI et al (2017) Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry 88:465–473. https://doi.org/10.1136/jnnp-2016-314895

Article  PubMed  Google Scholar 

Kouton L, Boucraut J, Devaux J et al (2020) Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins. Clin Neurophysiol 131:921–927. https://doi.org/10.1016/j.clinph.2020.01.013

Article  PubMed  Google Scholar 

Liu L, Chen J, Zhang Y, Wu J, Hu J, Lin Z (2022) Case report: immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy. Front Immunol 13:986018. https://doi.org/10.3389/fimmu.2022.986018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fehmi J, Davies AJ, Antonelou M et al (2023) Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis. PLoS One 18:e0281156. https://doi.org/10.1371/journal.pone.0281156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinkovits G, Szilágyi Á, Farkas P et al (2018) Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic purpura. Front Immunol 9:1646. https://doi.org/10.3389/fimmu.2018.01646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang CC, Lehman A, Albawardi A et al (2013) IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 26:799–805. https://doi.org/10.1038/modpathol.2012.237

Article  CAS  PubMed  Google Scholar 

Doppler K, Schuster Y, Appeltshauser L et al (2019) Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model. J Neuroinflammation 16:73. https://doi.org/10.1186/s12974-019-1462-z

Article  PubMed  PubMed Central  Google Scholar 

Appeltshauser L, Brunder AM, Heinius A et al (2020) Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy. Neurol Neuroimmunol Neuroinflamm 7:e817. https://doi.org/10.1212/NXI.0000000000000817

Article  PubMed  PubMed Central  Google Scholar 

Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N (2010) Conduction block in acute motor axonal neuropathy. Brain 133:2897–2908. https://doi.org/10.1093/brain/awq260

Article  PubMed  Google Scholar 

Devaux JJ, Miura Y, Fukami Y et al (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 86:800–807. https://doi.org/10.1212/WNL.0000000000002418

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ehrenreich T, Porush JG, Churg J et al (1976) Treatment of idiopathic membranous nephropathy. N Engl J Med 295:741–746. https://doi.org/10.1056/NEJM197609302951401

Article  CAS  PubMed  Google Scholar 

Manso C, Querol L, Mekaouche M, Illa I, Devaux JJ (2016) Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. Brain 139:1700–1712. https://doi.org/10.1093/brain/aww062

Article  PubMed  Google Scholar 

Doppler K, Appeltshauser L, Villmann C et al (2016) Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139:2617–2630. https://doi.org/10.1093/brain/aww189

Article  PubMed  Google Scholar 

Cortese A, Lombardi R, Briani C et al (2020) Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm 7:e639. https://doi.org/10.1212/NXI.0000000000000639

Article  PubMed  Google Scholar 

Bresciani L, Salvalaggio A, Vegezzi E et al (2023) Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: potential relevance of antibody titers in monitoring treatment response. J Peripher Nerv Syst 28:522–527. https://doi.org/10.1111/jns.12565

Article  CAS  PubMed  Google Scholar 

Koga M, Maeda T, Shimizu F, Kanda T (2023) Autoantibodies against contactin-associated protein 1 and complexes of paranode-specific proteins in chronic inflammatory demyelinating polyradiculoneuropathy. Clin Exp Neuroimmunol 14:116–121. https://doi.org/10.1111/cen3.12735

Article  CAS  Google Scholar 

Collins AM, Jackson KJ (2013) A temporal model of human IgE and IgG antibody function. Front Immunol 4:235. https://doi.org/10.3389/fimmu.2013.00235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oskam N, Damelang T, Streutker M et al (2023) Factors affecting IgG4-mediated complement activation. Front Immunol 14:1087532. https://doi.org/10.3389/fimmu.2023.1087532

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koneczny I, Tzartos J, Mané-Damas M et al (2022) IgG4 autoantibodies in organ-specific autoimmunopathies: reviewing class switching, antibody-producing cells, and specific immunotherapies. Front Immunol 13:834342. https://doi.org/10.3389/fimmu.2022.834342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 82:879–886. https://doi.org/10.1212/WNL.0000000000000205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huijbers MG, Querol LA, Niks EH et al (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22:1151–1161. https://doi.org/10.1111/ene.12758

Article  CAS  PubMed  Google Scholar 

Bertram M, Schröder JM (1993) Developmental changes at the node and paranode in human sural nerves: morphometric and fine-structural evaluation. Cell Tissue Res 273:499–509. https://doi.org/10.1007/BF00333704

Article  CAS  PubMed